Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02576496
What this trial is testing

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Hematological MalignanciesMultiple MyelomaHodgkin's Lymphoma+1 more
Mundipharma Research Limited 106
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Testing effectiveness (Phase 2)UnknownNCT03746652
What this trial is testing

Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hellenic Society of Hematology 50
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Testing effectiveness (Phase 2)Study completedNCT00229203
What this trial is testing

Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
PharmaMar 51
Early research (Phase 1)WithdrawnNCT04398680
What this trial is testing

Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function

Who this might be right for
Multiple Myeloma
GlaxoSmithKline
Testing effectiveness (Phase 2)Looking for participantsNCT06940297
What this trial is testing

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 44
Testing effectiveness (Phase 2)Study completedNCT00683046
What this trial is testing

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more
University of Chicago 204
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Early research (Phase 1)Ended earlyNCT05698888
What this trial is testing

Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors

Who this might be right for
Solid Tumors, AdultMultiple MyelomaLymphoma
Virtuoso BINco, Inc. 2
Testing effectiveness (Phase 2)Looking for participantsNCT05299424
What this trial is testing

CM336 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Keymed Biosciences Co.Ltd 48
Testing effectiveness (Phase 2)UnknownNCT04162119
What this trial is testing

Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT03104270
What this trial is testing

Combination Study for High Risk Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Oncotherapeutics 13
Early research (Phase 1)Study completedNCT03274219
What this trial is testing

Study of bb21217 in Multiple Myeloma

Who this might be right for
Multiple Myeloma
2seventy bio 72
Early research (Phase 1)Ended earlyNCT03994705
What this trial is testing

Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 20
Early research (Phase 1)Ended earlyNCT04178902
What this trial is testing

The Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Cancer
AbbVie 8
Testing effectiveness (Phase 2)Study completedNCT01962792
What this trial is testing

Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pharmacyclics LLC. 84
Early research (Phase 1)Ended earlyNCT03502577
What this trial is testing

BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 19
Large-scale testing (Phase 3)Study completedNCT01302392
What this trial is testing

Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 315
Next Page